Diabetes mellitus is a major global health challenge and a leading contributor to cardiovascular morbidity and mortality. Patients with diabetes develop accelerated and diffuse atherosclerosis, predisposing them to both coronary artery disease and peripheral arterial disease, frequently requiring surgical revascularization. Compared with non-diabetic patients, individuals with diabetes undergoing coronary artery bypass grafting or peripheral arterial bypass experience higher rates of perioperative complications, graft failure, and long-term adverse outcomes [1–4]. Imaging therefore plays a pivotal role in optimizing patient selection, procedural planning, and postoperative surveillance.

Recent advances in cardiovascular and vascular imaging have expanded the range of available noninvasive and minimally invasive techniques. However, diabetic-specific factors such as medial arterial calcification, chronic kidney disease, microvascular dysfunction, and multilevel disease complicate both image acquisition and interpretation. Despite widespread clinical use, uncertainty remains regarding the optimal sequencing, comparative effectiveness, and cost-efficiency of different imaging modalities in this population. This narrative review critically examines the current role of imaging across the perioperative course of vascular bypass surgery in diabetic patients, highlighting strengths, limitations, and gaps in the existing literature.

A narrative literature review was performed using PubMed/MEDLINE, PubMed Central, ScienceDirect, and the Cochrane Library. Searches covered the period from January 2020 to March 2025 and employed combinations of the terms “diabetes”, “coronary artery bypass”, “peripheral arterial disease”, “vascular bypass surgery” and “imaging”. English-language original studies, narrative reviews, and major guidelines addressing perioperative imaging in diabetic patients undergoing coronary or peripheral revascularization were included. Case reports, retracted articles, and studies not addressing surgical imaging were excluded. Titles and abstracts were screened followed by full-text review. Evidence was synthesized qualitatively with emphasis on diabetic-specific considerations, clinical applicability, and comparative insights across imaging modalities.

Preoperative imaging focuses on defining vascular anatomy, myocardial function, and tissue viability. Echocardiography remains investigation of choice for preoperative cardiac assessment. It has advanced techniques such as speckle-tracking enabling detection of subclinical myocardial dysfunction in diabetic patients with preserved ejection fraction (EF) as shown in Figure 1 highlighting that the 3D EF was within the normal range (52.7%) [5]. Computed tomography angiography provides high-resolution anatomical mapping of coronary and peripheral vessels, facilitating conduit selection and operative planning, although heavy calcification and contrast nephropathy limit its universal applicability in diabetics [6]. Figure 2 shows multivessel disease with significant stenosis in left anterior descending (LAD) and left circumflex coronary artery (LCX) along with reduced EF. Magnetic resonance angiography offers a radiation-free alternative in patients with renal impairment, albeit with lower spatial resolution and limited availability [7].

Intraoperatively, imaging is directed toward confirming graft quality and adequacy of revascularization. Transesophageal echocardiography enables real-time functional assessment, while Doppler-based transit-time flow measurement is widely used to verify graft patency during coronary bypass procedures [8]. Digital subtraction angiography, though invasive, remains indispensable in complex peripheral interventions requiring precise vascular detail [9], shown in Figure 3 in detail with severe stenosis of distal superficial femoral artery.

Postoperative imaging aims to detect early graft failure, disease progression, and procedure-related complications. Duplex ultrasound is the first-line modality for routine graft surveillance owing to its safety, accessibility, and cost-effectiveness [10]. Computed tomography angiography and magnetic resonance angiography are selectively employed when ultrasound findings are equivocal or when symptoms recur. Functional imaging using positron emission tomography or single-photon emission computed tomography as shown in Figure 4 illustrates mortality risk assessment and provides incremental prognostic information by assessing myocardial or tissue perfusion and viability, particularly in patients with persistent symptoms despite patent grafts [11].

Diabetic vasculopathy presents unique challenges for imaging. Medial arterial calcification reduces the diagnostic accuracy of duplex ultrasound and computed tomography angiography, while renal dysfunction restricts the use of iodinated contrast agents. Comparative evidence suggests that computed tomography angiography offers superior anatomical detail, whereas magnetic resonance angiography is preferable in patients with renal impairment [6, 7]. Functional imaging adds value in assessing myocardial viability and predicting benefit from revascularization, but its routine use is constrained by cost and limited accessibility. No single modality is sufficient in isolation; tailored multimodality strategies based on patient-specific risk profiles appear most effective.

Cost considerations are critical, particularly in low- and middle-income settings where the prevalence of diabetes is rising. Duplex ultrasound remains the most economical and widely available modality for both diagnosis and follow-up. Computed tomography angiography provides a favorable incremental cost-effectiveness ratio for operative planning but increases overall expenditure. Advanced and hybrid imaging techniques offer diagnostic advantages, but currently lack robust economic justification for routine use. A stepwise imaging approach, escalating from low-cost to advanced modalities as clinically indicated, is the most efficient strategy [11, 12].

Imaging is integral to the perioperative management of diabetic patients undergoing vascular bypass surgery. Advances in noninvasive and functional imaging have enhanced risk stratification, surgical planning, and postoperative surveillance (Table 1). Nevertheless, the available evidence remains largely observational, and diabetic-specific challenges persist. Standardized imaging pathways and high-quality comparative studies are required to define optimal imaging strategies and improve outcomes in this high-risk population.